Mirae Asset Global Etfs Holdings Ltd. Nuvalent, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 29,774 shares of NUVL stock, worth $2.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,774
Previous 24,862
19.76%
Holding current value
$2.38 Million
Previous $1.89 Million
61.45%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NUVL
# of Institutions
209Shares Held
59.5MCall Options Held
450KPut Options Held
619K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.6 Billion38.02% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5MShares$400 Million18.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$242 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.98MShares$238 Million7.96% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.44B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...